How the SP7 gene helps bone-forming cells become osteocytes
Comprehensive investigation of SP7 during the osteoblast-to-osteocyte transition
This project looks at how a specific SP7 gene mutation (R316C) changes the way bone-forming cells mature into osteocytes, which matters for people with inherited bone disorders like osteogenesis imperfecta.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project ID | NIH-11308352 on NIH RePORTER |
What this research studies
Researchers will model the human SP7 R316C mutation using laboratory and animal approaches to see how it blocks normal osteocyte development. They will capture developing osteocytes and use new laser-assisted microdissection to isolate cells embedded in bone for single-cell RNA sequencing. Bioinformatics will compare cell populations and identify which genes and subpopulations are affected by the mutation. The goal is to map the steps where maturation fails and point to molecular targets that could help guide future therapies.
Who could benefit from this research
Good fit: Ideal candidates would be people with inherited bone disease—especially those diagnosed with osteogenesis imperfecta or known to carry the SP7 R316C mutation—or donors able to provide bone tissue samples as controls.
Not a fit: People with common age-related osteoporosis or bone loss from other non-genetic causes may not receive direct benefit from this mutation-focused basic science work.
Why it matters
Potential benefit: If successful, this work could reveal the cellular steps and genes disrupted by an osteogenesis imperfecta–linked SP7 mutation and suggest targets for future treatments to improve bone health.
How similar studies have performed: Prior research has linked SP7 to osteocyte development and dendrite formation, but applying single-cell RNA sequencing and laser microdissection to study the human R316C mutation is a novel approach.
Where this research is happening
Dallas, United States
- Ut Southwestern Medical Center — Dallas, United States (Active)
Researchers
- Principal investigator: Wang, Jialiang — Ut Southwestern Medical Center
- Study coordinator: Wang, Jialiang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.